|
MLF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.616600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.224800E-01 |
| Normal-vs-Stage2 |
8.402200E-03 |
| Normal-vs-Stage3 |
4.577400E-01 |
| Normal-vs-Stage4 |
8.344800E-01 |
| Stage1-vs-Stage2 |
9.877400E-03 |
| Stage1-vs-Stage3 |
6.736400E-01 |
| Stage1-vs-Stage4 |
8.108200E-01 |
| Stage2-vs-Stage3 |
2.016200E-02 |
| Stage2-vs-Stage4 |
1.604040E-02 |
| Stage3-vs-Stage4 |
6.141000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.166400E-01 |
| Normal-vs-AfricanAmerican |
5.910200E-01 |
| Normal-vs-Asian |
6.784200E-01 |
| Caucasian-vs-AfricanAmerican |
9.279200E-01 |
| Caucasian-vs-Asian |
8.731200E-01 |
| AfricanAmerican-vs-Asian |
8.431400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.578600E-01 |
| Normal-vs-Female |
4.947200E-01 |
| Male-vs-Female |
3.000200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.451800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.853970E-01 |
| Normal-vs-Age(61-80Yrs) |
2.711600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.380400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.048560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.811960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.611000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.005000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.270800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.537200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.603200E-01 |
| Classical-VS-Follicular |
7.954600E-04 |
| Classical-VS-Other |
8.892400E-01 |
| Classical-VS-Normal |
6.735000E-01 |
| Tall-VS-Follicular |
6.648100E-04 |
| Tall-VS-Other |
4.667200E-01 |
| Tall-VS-Normal |
5.790200E-01 |
| Follicular-VS-Other |
1.059620E-01 |
| Follicular-VS-Normal |
2.197100E-03 |
| Other-VS-Normal |
7.326800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.613700E-02 |
| Normal-vs-N1 |
5.035600E-01 |
| N0-vs-N1 |
9.936600E-03 |
|
|
